BioPorto Announces Q3 2019 Report

    NEXT STORY
    Harpoon Therapeutics and AbbVie Announce Licensing and Option Collaboration to Advance HPN217, Harpoon’s BCMA-Targeting TriTAC®, and Expand Existing Discovery Collaboration
    PREV STORY
    Molecular Templates, Inc. Announces Proposed Public Equity Offering
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Immunovaccine to Present at 19th Annual Rodman & Renshaw Global Investment Conference

    HALIFAX, Nova Scotia, Aug. 30, 2017 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a ...

    author_avatar
    NASDAQ Market News

    aTyr Pharma to Participate at the BMO Prescriptions for Success Healthcare Conference

    SAN DIEGO, Dec. 07, 2017 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics ...

    author_avatar
    NASDAQ Market News

    Interpace Diagnostics Announces Agreement with Acupath Laboratories

    PARSIPPANY, N.J., March 28, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” ...

    author_avatar
    NASDAQ Market News